We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $53.9M | Put options by funds: $15.5M

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

24% more capital invested

Capital invested by funds: $2.09B → $2.6B (+$509M)

14% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 65

9% more funds holding

Funds holding: 205 → 224 (+19)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.26% less ownership

Funds ownership: 77.81% → 77.55% (-0.26%)

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
44
Increased
74
Reduced
65
Closed
25
Calls
$53.9M
Puts
$15.5M
Net Calls
+$38.4M
Net Calls Change
+$44.4M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$52.9M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$21.4M
3
EAM
Eventide Asset Management
Massachusetts
+$15.2M
4
HRCM
Hood River Capital Management
Florida
+$13.1M
5
NAMA
Nikko Asset Management Americas
New York
+$12.5M

Top Sellers

1
Temasek Holdings
Temasek Holdings
Singapore
-$62.3M
2
State Street
State Street
Massachusetts
-$44.1M
3
AIM
ARK Investment Management
Florida
-$17.2M
4
DTC
Deep Track Capital
Connecticut
-$14.3M
5
Millennium Management
Millennium Management
New York
-$13.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
William Blair & Company
151
William Blair & Company
Illinois
$252K -$57K -1,000 -16%
Commonwealth Equity Services
152
Commonwealth Equity Services
Massachusetts
$241K -$70.3K -1,232 -20%
YMRC
153
Yorktown Management & Research Company
Virginia
$238K +$286K +5,005 New
AIP
154
Ameritas Investment Partners
Nebraska
$237K +$12.3K +216 +5%
JMPWA
155
JP Morgan Private Wealth Advisors
California
$225K +$269K +4,715 New
Mercer Global Advisors
156
Mercer Global Advisors
Colorado
$223K +$267K +4,683 New
XT
157
XTX Topco
Cayman Islands
$216K +$258K +4,524 New
GT
158
Glenmede Trust
Pennsylvania
$216K +$260K +4,552 New
Handelsbanken Fonder
159
Handelsbanken Fonder
Sweden
$210K +$251K +4,400 New
VIA
160
Vident Investment Advisory
Georgia
$209K +$150K +2,629 +47%
PAMS
161
Pictet Asset Management (Switzerland)
Switzerland
$201K +$240K +4,213 New
JAMONY
162
Jacob Asset Management of New York
California
$197K +$19K +333 +9%
MLICM
163
Metropolitan Life Insurance Company (MetLife)
New York
$183K – – –
Canada Pension Plan Investment Board
164
Canada Pension Plan Investment Board
Ontario, Canada
$167K -$103K -1,800 -34%
Amundi
165
Amundi
France
$148K – – –
Canada Life
166
Canada Life
Manitoba, Canada
$142K +$4.22K +74 +3%
BAM
167
Belpointe Asset Management
Nevada
$137K +$164K +2,875 New
Allspring Global Investments
168
Allspring Global Investments
North Carolina
$102K +$43.8K +767 +55%
KIG
169
Kessler Investment Group
Indiana
$83K +$99.3K +1,740 New
Nisa Investment Advisors
170
Nisa Investment Advisors
Missouri
$64K +$19.6K +344 +31%
FFA
171
Fairfield Financial Advisors
Massachusetts
$60.3K – – –
Rockefeller Capital Management
172
Rockefeller Capital Management
New York
$58K -$27.7K -485 -28%
HIA
173
Harbor Investment Advisory
Maryland
$48K – – –
CUAMC
174
China Universal Asset Management Company
China
$43K +$51.1K +895 New
IUHSA
175
Itau Unibanco Holding S.A.
Brazil
$38K -$21.1K -370 -32%
5 6
7
8 9

BEAM Hedge Fund Activity: Q3 2022 in Review

224 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2022, worth a combined $2.6B — up 24% from $2.09B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new BEAM positions and 25 closed out — a net gain of 19 holders — while 74 added to existing stakes and 65 trimmed.

The largest buyer was Vanguard Group, adding an estimated $52.9M. The largest seller was Temasek Holdings, cutting an estimated $62.3M.

  • 224 institutional investors held Beam Therapeutics (BEAM) as of Q3 2022, up from 205 in Q2 2022.
  • Funds reported $2.6B of Beam Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 44 funds opened new Beam Therapeutics positions in Q3 2022 and 25 closed out, a net change of +19 holders.
  • The largest Beam Therapeutics buyer in Q3 2022 was Vanguard Group, an estimated $52.9M added.
  • The largest Beam Therapeutics seller in Q3 2022 was Temasek Holdings, an estimated $62.3M sold.

Based on aggregated 13F filings for Q3 2022.